A carregar...
Publicação
Fidaxomicin for Clostridiodes difficile infection in inflammatory bowel disease: a multicenter retrospective cohort study
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 2.25 MB | Adobe PDF |
Orientador(es)
Resumo(s)
Inflammatory bowel disease (IBD) patients with Clostridiodes difficile Infection (CDI) are at increased risk of disease exacerbations, therapy escalation, colectomy, and mortality. Data on fidaxomicin use in IBD patients with CDI are very limited. We aimed to assess the effectiveness and safety of fidaxomicin for CDI and its impact on IBD outcomes in a large retrospective multicenter cohort study
Descrição
Palavras-chave
Contexto Educativo
Citação
Editora
Oxford University Press